U.S. Markets open in 1 hr 16 mins
  • S&P Futures

    3,863.25
    +15.00 (+0.39%)
     
  • Dow Futures

    31,163.00
    +150.00 (+0.48%)
     
  • Nasdaq Futures

    11,938.75
    +58.50 (+0.49%)
     
  • Russell 2000 Futures

    1,737.60
    +9.00 (+0.52%)
     
  • Crude Oil

    99.72
    +1.19 (+1.21%)
     
  • Gold

    1,742.60
    +6.10 (+0.35%)
     
  • Silver

    19.34
    +0.19 (+0.97%)
     
  • EUR/USD

    1.0183
    -0.0001 (-0.0102%)
     
  • 10-Yr Bond

    2.9130
    0.0000 (0.00%)
     
  • Vix

    26.82
    -0.72 (-2.61%)
     
  • GBP/USD

    1.1963
    +0.0041 (+0.3433%)
     
  • USD/JPY

    135.6460
    -0.2690 (-0.1979%)
     
  • BTC-USD

    20,459.82
    +476.01 (+2.38%)
     
  • CMC Crypto 200

    440.06
    +4.54 (+1.04%)
     
  • FTSE 100

    7,197.51
    +89.74 (+1.26%)
     
  • Nikkei 225

    26,490.53
    +382.88 (+1.47%)
     

ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at approximately 1:30 p.m. (Eastern Standard Time) via webcast.

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. Conference attendees will be able to access the video webcast via the J.P. Morgan Digital Conference Book. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 9, 2022.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors

For media

Amy Wakeham

Jayme Rubenstein

+1 858.836.5000

+1 858.836.6798

investorrelations@resmed.com

news@resmed.com